Skip to contentN
Nutra Pharma Corp
N
NPHCNutra Pharma Corp Q4 2015 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$39.37K$39.37Kderived−76.3% vs Q4 2014 Net Income$676.10K$676.10KderivedN/M vs Q4 2014 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$30,766−75.7% Operating Incomederived-$560,569N/M Operating Cash Flowderived-$190,382N/M Free Cash Flowderived-$190,382N/M Margins · derivedGross margin78.1%+1.6 pt vs Q4 2014
Operating margin-1423.8%−934.7 pt vs Q4 2014
Net margin1717.2%+2201.0 pt vs Q4 2014
ended Dec 31, 2015 · filed Apr 14, 2016 · 105 d after period end